Skip to content
OpenCapital
Get started

Sanara MedTech Inc. SMTI Other Debt Including Capitalized Leases

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S2×-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLongTermDebt.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s other debt including capitalized leases.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s other debt including capitalized leases?
Sanara MedTech Inc. (SMTI) reported other debt including capitalized leases of $559.6K in Q1 2026.
How has Sanara MedTech Inc.'s other debt including capitalized leases changed year-over-year?
Sanara MedTech Inc.'s other debt including capitalized leases decreased by 52.1% year-over-year, from $1.17M to $559.6K.
What is the long-term trend for Sanara MedTech Inc.'s other debt including capitalized leases?
Over 2 years (2023 to 2025), Sanara MedTech Inc.'s other debt including capitalized leases has grown at a -46.9% compound annual growth rate (CAGR), from $1.94M to $548.13K.